Institutional ZCube December 21, 2020 HEALTHCARE AND INNOVATION: UP TO €100,000 TO THE STARTUP THAT ADDRESSES WOMEN’S HEALTH ISSUES
Scientific Zambon Pharma November 19, 2020 The importance of protecting the lungs from oxidative stress for COPD patients
Scientific Zambon Pharma September 14, 2020 Zambon announces its Symposium at MDS Virtual Congress 2020: Challenges in the management of Parkinson’s Disease patients during COVID-19 pandemic: What can we expect?
Scientific Zambon Pharma September 9, 2020 At the Symposium "Which target to protect and preserve lung health?" we talked about the management of patients with chronic lung diseases and new evidence in COVID-19 scientific research
Scientific Zambon Pharma February 20, 2020 Breath Therapeutics, a Zambon company, initiates BOSTON-3 and BOSTON-4, two additional clinical studies for the treatment of bronchiolitis obliterans syndrome (BOS)
Scientific Zambon Pharma November 13, 2019 Zambon entered in an exclusive license agreement to register and commercialize riluzole Oral Film in Europe for ALS
